Skin cancer in solid organ transplant recipients: Advances in therapy and management: Part II. Management of skin cancer in solid organ transplant recipients

Journal of the American Academy of Dermatology

Volumn 65, Issue 2, 2011, Pages 253-261

  O'Reilly Zwald, Fiona ^a   Brown, Marc ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

immunosuppression; nonmelanoma skin cancer; organ transplant recipients; radiotherapy; sentinel lymph node biopsy

Indexed keywords

AZATHIOPRINE; B RAF KINASE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN; CYTOCHROME P450; DACLIZUMAB; DNA; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MONOMURAB CD3; MYCOPHENOLIC ACID; OKT 3; PREDNISONE; PROTEIN E6; PROTEIN E7; PROTEIN P53; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; TIOGUANINE; UNCLASSIFIED DRUG; VORICONAZOLE;

ACTINIC KERATOSIS; ACUTE GRAFT REJECTION; AFRICAN AMERICAN; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; BONE MARROW SUPPRESSION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RISK; CANCER SURGERY; CARCINOGENESIS; CARCINOGENICITY; CELL DEATH; DNA SYNTHESIS; DORSAL SURFACE OF THE HAND; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG TOLERABILITY; EDEMA; ERYTHEMA; FLAT WART; FOLLOW UP; GENE MUTATION; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HAND; HEAD AND NECK CANCER; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 15; HUMAN PAPILLOMAVIRUS TYPE 8; HUMAN PAPILLOMAVIRUS TYPE 9; HYPERLIPIDEMIA; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INVASIVE ASPERGILLOSIS; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; LEUKEMIA; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; LYMPH NODE METASTASIS; LYMPHOMA; MAINTENANCE THERAPY; MELANOCYTE; MELANOMA; MERKEL CELL TUMOR; METASTASIS; MONOTHERAPY; MORBIDITY; MORTALITY; NONMELANOMA SKIN CANCER; ORGAN TRANSPLANTATION; OVERALL SURVIVAL; OXIDATIVE STRESS; PAPILLOMA; PHOTOSENSITIVITY; PHOTOSENSITIZATION; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; QUALITY OF LIFE; RECURRENCE RISK; RISK ASSESSMENT; RISK REDUCTION; SEBORRHEIC KERATOSIS; SENTINEL LYMPH NODE BIOPSY; SEX RATIO; SIDE EFFECT; SKIN BIOPSY; SKIN CANCER; SKIN DEFECT; SOLID ORGAN TRANSPLANT; SQUAMOUS CELL CARCINOMA; STEM CELL TRANSPLANTATION; SUN EXPOSURE; SUNBURN; T LYMPHOCYTE ACTIVATION; THICKNESS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; ULCER; ULTRAVIOLET A RADIATION; ULTRAVIOLET RADIATION; VASCULARIZATION; VERRUCA VULGARIS; VISION; WART VIRUS; WEGENER GRANULOMATOSIS; WOUND HEALING;

EID: 79960411586     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.11.062     Document Type: Review

References (73)

1. L.J. Christenson, A. Geusau, C. Ferrandiz, C.D. Brown, C. Ulrich, and E. Stockfleth Specialty clinics for the dermatologic care of solid-organ transplant recipients Dermatol Surg 30 4 pt 2 2004 598 603 (Pubitemid 38525888)
2. D.C. Seukeran, C.G. Newstead, and W.J. Cunliffe The compliance of renal transplant recipients with advice about sun protection measures Br J Dermatol 138 1998 301 303 (Pubitemid 28114136)
3. F. Ismail, L. Mitchell, D. Casabonne, A. Gulati, R. Newton, and C.M. Proby Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness Br J Dermatol 155 2006 916 925 (Pubitemid 44564499)
4. H.E. Clowers-Webb, L.J. Christenson, P.K. Phillips, R.K. Roenigk, T.H. Nguyen, and A.L. Weaver Educational outcomes regarding skin cancer in organ transplant recipients: randomized intervention of intensive vs standard education Arch Dermatol 142 2006 712 718
5. I. Feuerstein, and A.C. Geller Skin cancer education in transplant patients Prog Transplant 18 2008 232 241
6. C. Ulrich, J.S. Jürgensen, A. Degen, M. Hackethal, M. Ulrich, and M.J. Patel Prevention of non-melanoma skin cancer in organ transplant recipients by regular use of a sunscreen: a 24 months, prospective, case-control study Br J Dermatol 161 suppl 3 2009 78 84
7. J. Reichrath, and B. Nurnberg Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs) Adv Exp Med Biol 624 2008 203 214
8. D. Ducloux, C. Courivaud, J. Bamoulid, A. Kazory, G. Dumoulin, and J.M. Chalopin Pretransplant serum vitamin D levels and risk of cancer after renal transplantation Transplantation 85 2008 1755 1759
9. F. O'Reilly, C. Traywick, M.L. Pennie, J.K. Foster, and S.C. Chen Baseline quality of life and anxiety in solid organ transplant recipients: a pilot study Dermatol Surg 32 2006 1480 1485 (Pubitemid 44934897)
10. F.J. Moloney, S. Keane, P. O'Kelly, P.J. Conlon, and G.M. Murphy The impact of skin disease following renal transplantation on quality of life Br J Dermatol 153 2005 574 578 (Pubitemid 41248215)
11. T. Stasko, M.D. Brown, J.A. Carucci, S. Euvrard, T.M. Johnson, and R.D. Sengelmann Guidelines for the management of squamous cell carcinoma in organ transplant recipients Dermatol Surg 30 4 pt 2 2004 642 650 (Pubitemid 38525895)
12. B.T. Kovach, and T. Stasko Use of topical immunomodulators in organ transplant recipients Dermatol Ther 18 2005 19 27 (Pubitemid 40685544)
13. V.L. Brown, C.L. Atkins, L. Ghali, R. Cerio, C.A. Harwood, and C.M. Proby Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial Arch Dermatol 141 2005 985 993 (Pubitemid 46165522)
14. C. Ulrich, J.O. Busch, T. Meyer, I. Nindl, T. Schmook, and W. Sterry Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases Br J Dermatol 155 2006 451 454 (Pubitemid 44050583)
15. N.C. Zeitouni, A.R. Oseroff, and S. Shieh Photodynamic therapy for nonmelanoma skin cancers. Current review and update Mol Immunol 39 2003 1133 1136 (Pubitemid 36776569)
16. C.M. Perrett, J.M. McGregor, J. Warwick, P. Karran, I.M. Leigh, and C.M. Proby Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5 fluorouracil cream and topical photodynamic therapy Br J Dermatol 156 2007 320 328 (Pubitemid 46095961)
17. S. Piaserico, A. Belloni Fortina, P. Rigotti, B. Rossi, N. Baldan, and M. Alaibac Topical photodynamic therapy of actinic keratosis in renal transplant recipients Transplant Proc 39 2007 1847 1850 (Pubitemid 47198804)
18. P. Mikolajewska, V. Iani, A. Juzeniene, and J. Moan Topical aminolevulinic acid and aminolevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema Br J Dermatol 161 2009 1173 1179
19. H.C. Wulf, S. Pavel, I. Stender, and C.A. Bakker-Wensveen Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients Acta Derm Venereol 86 2006 25 28 (Pubitemid 46939784)
20. Y.G. de Graaf, C. Kennedy, R. Wolterbeek, A.F. Collen, R. Willemze, and J.N. Bouwes Bavinck Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ transplant recipients: results of a randomized-controlled trial J Invest Dermatol 126 2006 569 574 (Pubitemid 43255643)
21. A. Wiley, S. Mehta, and P.L. Lee Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy Dermatol Surg 36 2009 652 659
22. Y.G. de Graaf, V.R. Basdew, N. van Zwan-Kralt, R. Willemze, and J.N. Bavinck The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodessication Br J Dermatol 154 2006 493 497 (Pubitemid 43382658)
23. J.N. Bavinck, L.M. Tieben, F.J. Van der Woude, A.M. Tegzess, J. Hermans, and J. ter Schegget Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo controlled study J Clin Oncol 13 1995 1933 1938
24. C.A. Harwood, M. Leedham-Greene, I.M. Leigh, and C.M. Proby Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients Arch Dermatol 141 2005 456 464 (Pubitemid 40547404)
25. J.J. DiGiovanna Retinoid chemoprevention in the high-risk patient J Am Acad Dermatol 39 2 pt 3 1998 S82 S85
26. D.B. McKenna, and G.M. Murphy Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin Br J Dermatol 140 1999 656 660 (Pubitemid 29191384)
27. R. George, W. Weightman, G.R. Russ, K.M. Bannister, and T.H. Mathew Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients Australas J Dermatol 43 2002 269 273 (Pubitemid 35365416)
28. J.C. Martinez, C.C. Otley, T. Stasko, S. Euvrard, C. Brown, and C.F. Schanbacher Defining the course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study Arch Dermatol 139 2003 301 306 (Pubitemid 36330577)
29. B.T. Kovach, H.H. Sams, and T. Stasko Systemic strategies for chemoprevention of skin cancers in transplant recipients Clin Transplant 19 2005 726 734 (Pubitemid 41748724)
30. C.C. Otley, T. Stasko, W.D. Tope, and M. Lebwohl Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects Dermatol Surg 32 2006 562 568
31. I. Leibovitch, S.C. Huilgol, D. Selva, D. Hill, S. Richards, and R. Paver Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia. Experience over 10 years J Am Acad Dermatol 53 2005 253 260 (Pubitemid 40979582)
32. T. Stasko, M.D. Brown, J.A. Carucci, S. Euvrard, T.M. Johnson, and R.D. Sengelmann Guidelines for the management of squamous cell carcinoma in organ transplant recipients Dermatol Surg 30 4 pt 2 2004 642 650 (Pubitemid 38525895)
33. J.Z. Cooper, and M.D. Brown Special concern about squamous cell carcinoma of the scalp in organ transplant recipients Arch Dermatol 142 2006 755 758
34. K.D. Brantsch, C. Meisner, B. Schönfisch, B. Trilling, J. Wehner-Caroli, and M. Röcken Analysis of risk factors determining the prognosis of cutaneous squamous-cell carcinoma: a prospective study Lancet Oncol 9 2008 713 720
35. M.J. Veness, C.E. Palme, and G.J. Morgan High-risk squamous cell carcinoma of the head and neck. Results from 266 treated patients with metastatic lymph node disease Cancer 23 2006 2389 2396 (Pubitemid 43787663)
36. L. Peramiquel, and A. Alomar Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment J Am Acad Dermatol 55 5 suppl 2006 S119 S120
37. U. Wollina, G. Hansel, A. Koch, and E. Köstler Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin J Cancer Res Clin Oncol 131 2005 300 304 (Pubitemid 40558545)
38. M. Dooley, and K.L. Goa Capecitabine Drugs 58 1999 69 76 (Pubitemid 29373887)
39. B.T. Endrizzi, and P.K. Lee Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine Dermatol Surg 35 2009 1567 1572
40. J.D. Wagner, D.Z. Evdokimow, E. Weisberger, D. Moore, T.Y. Chuang, and S. Wenck Sentinel lymph node biopsy for high-risk nonmelanoma cutaneous malignancy Arch Dermatol 140 2004 75 79 (Pubitemid 38090273)
41. A.S. Ross, and C.D. Schmults Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: as systematic review of the English literature Dermatol Surg 32 2006 1309 1321 (Pubitemid 44691132)
42. D.E. Rowe, R.J. Carroll, and C.L. Day Jr. Prognostic factors for local recurrence, metastasis and survival rates in squamous cell carcinoma of the skin, ear and lip. Implications for treatment modality selection J Am Acad Dermatol 26 1992 976 990
43. M.J. Veness, G.J. Morgan, and C. Palme Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes: surgery and adjuvant radiotherapy should be considered best practice Laryngoscope 44 2005 870 875 (Pubitemid 40604696)
44. A. Garcia-Serra, R.W. Hinerman, W.M. Mendenhall, R.J. Amdur, C.G. Morris, and L.S. Williams Carcinoma of the skin with perineural invasion Head Neck 25 2003 1027 1033 (Pubitemid 37475265)
45. A.J. Ballantyne, A.B. McCarten, and M.L. Ibanez The extension of cancer of the head and neck area through peripheral nerves Am J Surg 106 1963 651 667
46. I. Leibovitch, S.C. Huilgol, D. Selva, D. Hill, S. Richards, and R. Paver Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion J Am Acad Dermatol 53 2005 261 266 (Pubitemid 40979583)
47. T.A. Padhya, R.S. Cornelius, S.M. Athavale, and J.L. Gluckman Perineural extension to the skull base from early cutaneous malignancies of the midface Otolaryngol Head Neck Surg 137 2007 742 746 (Pubitemid 47632929)
48. A. Han, and D. Ratner What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion? Cancer 109 2007 1053 1059 (Pubitemid 46435382)
49. C.C. Otley, D. Berg, C. Ulrich, T. Stasko, G.M. Murphy, and S.J. Salasche Reduction of immunosuppression for transplant associated skin cancer: expert consensus survey Br J Dermatol 154 2006 395 400 (Pubitemid 43382643)
50. H. Tsao, M.B. Atkins, and A.J. Sober Management of cutaneous melanoma N Engl J Med 351 2004 998 1012
51. F.O. Zwald, L.J. Christenson, E.M. Billingsley, N.C. Zeitouni, D. Ratner, and J. Bordeaux Melanoma in solid organ transplant recipients Am J Transplant 10 2010 1297 1304
52. I. Penn Transmission of cancer from organ donors Ann Transplant 2 1997 7 12
53. S.M. Dinehart, and S.V. Pollack Metastases from squamous cell carcinoma of the skin and lip: an analysis of twenty-seven cases J Am Acad Dermatol 21 2 pt 1 1989 241 248 (Pubitemid 19195886)
54. D.E. Rowe, R.J. Carroll, and C.L. Day Prognostic factors for local recurrence, metastasis and survival rates in squamous cell carcinoma of the skin, ear and lip J Am Acad Dermatol 26 1992 976 990
55. J.G. Vartanian, A.L. Carvalho, M.J. de Araújo Filho, M.H. Junior, J. Magrin, and L.P. Kowalski Predictive factors and distribution of lymph node metastasis in lip cancer patients and their implications on the treatment of the neck Oral Oncol 40 2004 23 227
56. J.A. Carucci, J.C. Martinez, N.C. Zeitouni, L. Christenson, B. Coldiron, and S. Zweibel In-transit metastasis from primary cutaneous squamous cell in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management and outcome in a series of 21 patients Dermatol Surg 30 4 pt 2 2004 651 655 (Pubitemid 38525896)
57. M.J. Veness, S. Porceddu, C.E. Palme, and G.J. Morgan Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes Head and Neck 29 2007 621 631 (Pubitemid 47168232)
58. J.S. Cooper, T.F. Pajak, A.A. Forastiere, J. Jacobs, B.H. Campbell, and S.B. Saxman Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck New Engl J Med 350 2004 1937 1944
59. K.E. Southwell, J.M. Chaplin, R.L. Eisenberg, N.P. McIvor, and R.P. Morton Effect of immunecompromise on metastatic cutaneous squamous cell carcinoma of the parotid and neck Head Neck 28 2006 244 248 (Pubitemid 43269891)
60. J.C. Martinez, C.C. Otley, S.H. Okuno, R.L. Foote, and J.L. Kasperbauer Chemotherapy in the setting of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations Dermatol Surg 30 2004 679 686 (Pubitemid 38525901)
61. J. Marshall Clinical implications for the mechanism of epidermal growth factor inhibitors Cancer 107 2006 1207 1218 (Pubitemid 44452768)
62. J.E. Bauman, K.D. Eaton, and R.G. Martins Treatment of recurrent squamous cell carcinoma of the skin with cetuximab Arch Dermatol 143 2007 889 892 (Pubitemid 47076487)
63. W.L. Read Squamous carcinoma of the skin responding to erlotinib: three cases J Clin Oncol 25 18S 2007 16519
64. J.A. Bonner, P.M. Harari, J. Giralt, N. Azarnia, D.M. Shin, and R.B. Cohen Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578 (Pubitemid 43209104)
65. L.E. Leard, B.K. Cho, K.D. Jones, S.R. Hays, W.D. Tope, and J.A. Golden Fatal diffuse alveolar damage in two lung transplant patients treated with cetuximab J Heart Lung Transplant 26 2007 1340 1344 (Pubitemid 350256993)
66. S. Benavente, S. Huang, E.A. Armstrong, A. Chi, K.T. Hsu, and D.L. Wheeler Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cells Clin Cancer Res 15 2009 1585 1592
67. C.H. Chung, B. Mirakhur, E. Chan, Q.T. Le, J. Berlin, and M. Morse Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose N Engl J Med 358 2008 1109 1117 (Pubitemid 351398485)
68. T.A. Weaver, A.H. Charafeddine, A. Agarwal, A.P. Turner, M. Russell, and F.V. Leopardi Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates Nat Med 15 2009 746 749
69. T.A. Weaver, and A.D. Kirk Alemtuzumab Transplantation 84 2007 1545 1547
70. S. Delis, G.W. Burke 3rd, and G. Ciancio Bone marrow-induced tolerance in the era of pancreas and islets transplantation Pancreas 32 2006 1 8 (Pubitemid 41803640)
71. J.A. Emamaullee, S. Merani, C.P. Larsen, and A.M. Shapiro Belatacept and basiliximab diminish human antiporcine xenoreactivity and synergize to inhibit alloimmunity Transplantation 85 2008 118 124
72. M.H. Dahlke, M. Hoogduijn, E. Eggenhofer, F.C. Popp, P. Renner, and P. Slowik Toward MSC in solid organ transplantation: 2008 position paper of the MISOT study group Transplantation 88 2009 614 619
73. B. Ekser, P. Rigotti, B. Gridelli, and D.K. Cooper Xenotransplantation of solid organs in the pig-to-primate model Transpl Immunol 21 2009 87 92